Citius Pharmaceuticals, Inc. Purchase Obligation, to be Paid, Year One
Citius Pharmaceuticals, Inc. (CTXR) had Purchase Obligation, to be Paid, Year One of $6.30 million as of 2025-12-31, per its 10-Q filed 2026-02-13.
Financial Statements › Notes › Commitment and Contingencies › Purchase Obligation, Fiscal Year Maturity
us-gaap:PurchaseObligationDueInNextTwelveMonths · last filed 2026-02-13
- 2025-12-31: Purchase Obligation, to be Paid, Year One $6.30M.
- 2025-09-30: Purchase Obligation, to be Paid, Year One $1.90M.
- 2025-06-30: Purchase Obligation, to be Paid, Year One $1.60M.
- 2025-03-31: Purchase Obligation, to be Paid, Year One $1.60M.
| Period end | Purchase Obligation, to be Paid, Year One |
|---|---|
| 2025-12-31 | $6.30M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $1.90M 10-K · filed 2025-12-23 |
| 2025-06-30 | $1.60M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $1.60M 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |